BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3181045)

  • 21. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
    McCrindle BW; Ose L; Marais AD
    J Pediatr; 2003 Jul; 143(1):74-80. PubMed ID: 12915827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperlipoproteinemia: diagnosis and management.
    Shakir KM
    Prim Care; 1976 Jun; 3(2):277-91. PubMed ID: 1047448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dyslipidemias].
    Spoto S; Navajas Martinez MF; Costantino S
    Clin Ter; 2003; 154(1):65-9. PubMed ID: 12854288
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of hypolipemic agents on levels of total plasma homocysteine].
    Dvoráková J; Dubská L; Táborský L; Hyánek J
    Vnitr Lek; 2001 Oct; 47(10):674-7. PubMed ID: 11789004
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Caniggia A; Gennari C; Picchi M
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1416-22. PubMed ID: 4218488
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mixed hyperlipemia with a distinct accumulation of beta and prebeta lipoproteins (apropos of 78 cases)].
    Loeper J; Rouffy J; Loeper J
    Arch Mal Coeur Vaiss; 1970-1971; 12():Suppl 1:3-15. PubMed ID: 5004789
    [No Abstract]   [Full Text] [Related]  

  • 29. [The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].
    Union Med Can; 1994 Apr; 123(4):249-58. PubMed ID: 8203048
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing hyperlipidaemia.
    Nestel PJ
    Med J Aust; 1988 Jan; 148(1):29-31. PubMed ID: 3336296
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Bracaglia D; Cordova C
    Clin Ter; 1994 Jan; 144(1):3-9. PubMed ID: 8168349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of primary hyperlipidemia with 5-methylpyrazinecarboxylic acid (acipimox)].
    Quintão EC; de Castilho LN
    Arq Bras Cardiol; 1985 Jan; 44(1):37-40. PubMed ID: 4062591
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G; Cazzani E; Romanò M; Muzio L
    Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 36. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 37. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of disorders of lipid metabolism with the new lipid regulator X50].
    Reuter W; Herrmann W; Sauer I; Janowski K; Dorn H; Steinicke A
    Z Gesamte Inn Med; 1986 Mar; 41(5):124-6. PubMed ID: 3754999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
    Vailati G; Montini M; Simonutti M; Nosari I; Pagani G
    Clin Ter; 1978 May; 85(4):361-73. PubMed ID: 668273
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperlipemia and pancreatitis].
    Carrillo Penso N; Carrasquero O; Medina JA
    G E N; 1981; 35(1-2):15-27. PubMed ID: 6816659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.